Evidence map›Paper›PMID 42798845›Full record

ArticleCureus2026

A Rare Dual Complication of First-Line Anti-tubercular Therapy: A Case Report of Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome and Ethambutol-Induced Optic Neuropathy.

Koustav Kundu, Aouf Alazzawi

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Koustav KunduAcute and General Internal Medicine, Bedford Hospital, Bedfordshire Hospitals NHS Foundation Trust, Bedford, GBR.
Aouf AlazzawiAcute and General Internal Medicine, Bedford Hospital, Bedfordshire Hospitals NHS Foundation Trust, Bedford, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is an extremely rare and serious systemic drug reaction, often posing significant diagnostic challenge to clinicians. Ethambutol-induced optic neuropathy (EON) is a well-recognised but often insidious complication of first-line anti-tubercular therapy (ATT), typically manifesting as reduced visual acuity, and visual field defects. We report the case of a 78-year-old woman with confirmed diagnosis of pulmonary tuberculosis, who simultaneously developed probable DRESS syndrome, secondary to rifampicin and EON shortly after initiation of the standard first-line ATT regimen (isoniazid, rifampicin, pyrazinamide, and ethambutol). Early diagnosis and prompt withdrawal of the offending drugs helped her to achieve complete recovery with no complications. This case highlights the importance of a high index of suspicion and early recognition of drug-induced adverse reactions in patients on multi-drug ATT regimens, as timely diagnosis and management can help in preventing serious complications like permanent vision loss, and also death.

Indexed as

anti-tubercular therapy (att)drug hypersensitivity reactionsdrug reaction with eosinophilia and systemic symptoms (dress) syndromeethambutol-induced optic neuropathy (eon)tuberculosis

Identifiers

PMID42798845
PMCPMC13613185

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.